US Flu Vaccine [Influenza Vaccine] Market Analysis and in-Depth Research on Market Dynamics, Trends, Emerging Growth Factors and Forecasts to 2025


Posted November 28, 2019 by dpiresearch

DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report.
 
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the flu vaccines market with respect to growth trends, future prospects, and their contribution to the total market.

The United States influenza vaccines market size is anticipated to observe tremendous growth projections during 2019 – 2025.

The prominent factors that are expected to contribute to the growth of the US Influenza vaccines market during the forecast period:

Increased Disease Awareness
Approval/launches of the New Influenza Vaccines
Expanded Recommendations by Governmental and Advisory Bodies to be Vaccinated against Influenza Vaccines
Introduction of the Quadrivalent Influenza Vaccines
Highlighted with 17 tables and 16 figures, this 145-page report “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” is based on comprehensive research of the entire United States influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States influenza vaccines market. The report provides historical market data for 2013 – 2018, and forecasts from 2019 till 2025.

The report contains a deep analysis of the US influenza vaccines market with size in terms of both value and volume of the US influenza vaccines market. The report provides clear insight into current and future developments of the United States influenza vaccines market. The report also explores detailed analysis of the children and adults vaccinated with influenza vaccines in United States from 2013 to 2018 and forecasts to 2025. The report also details the latest information about the influenza vaccines production, supply, and allocation by major companies in the United States.

A comprehensive analysis has been done on pricing, distribution & demand and effectiveness of the influenza vaccines in the United States. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Furthermore, this topical report describes the features reimbursement pattern and offers a clear view of the regulatory framework. Additionally, the report comprises assessment of clinical trials, reviews promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025.

The report also provides comprehensive profiles of the dominant players in the country’s influenza vaccines market such as Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and AstraZeneca with important details on companies’ vaccines portfolio, sales, strategies, and the latest developments. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, and Biondvax Pharmaceuticals Ltd, are making novel technology-based influenza vaccines which are likely to affect the market share during the forecast period.

Key Topics Covered in the Report:

The Market Size of the United States Influenza Vaccines Market
Scrutinizes the US Overall Persons Being Vaccinated with Influenza Vaccines
Scrutinizes the US Children Being Vaccinated with Influenza Vaccines
Scrutinizes the US Adults Being Vaccinated with Influenza Vaccines
Provides Comprehensive Insights on the Latest Pricing Trends and Analysis
Includes a Detailed Analysis of the US Influenza Vaccines Production, Supply, and Allocation (By Companies)
Delivers a Complete Overview of the US Influenza Vaccines Distribution and Demand
Examines the Effectiveness of the Influenza Vaccines in the United States
Detailed Assessment of the Rapid Diagnostic Testing for the Management of Influenza
Thoroughly Evaluates of the Distribution Channel and Technique of the Influenza Vaccination in the United States
Detailed Insights of the Regulatory Framework, Features Reimbursement Patterns of the US Influenza Vaccines
Provides Key Trends with Respect to Collaboration, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement
An Insightful Analysis of the Promising Influenza Vaccines in the Clinical Development
Reviews Most Recent Clinical Trials of the Influenza Vaccines
Investigates the Key Growth Drivers and Restraints of the US Influenza Vaccines Market
A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development
The Report Helps Answer the Following Questions:

What is the size of the influenza vaccines market in the United States?
How many persons being vaccinated with influenza vaccines in the US during 2013 – 2025?
What are the key drivers and restraints in the current market?
What are the various influenza vaccines available in the United States?
How is the market predicted to develop in the future?
Who are the key players in this market space?
Key Topics Covered

1. Executive Summary

2. United States Influenza Vaccines Market Size & Analysis (2013 – 2025)

3. United States Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
3.1 Number of Children Vaccinated with Influenza Vaccines
3.2 Number of Adults Vaccinated with Influenza Vaccines

4. Key Drivers and Inhibitors of the United States Influenza Vaccines Market
4.1 Market Drivers
4.2 Market Restraints

5. United States Influenza Vaccines Pricing Trends & Analysis

6. United States Influenza Vaccines Production, Supply, and Allocation (By Companies)

7. United States Influenza Vaccines Distribution & Demand (2010 – 2019)

8. Effectiveness of Influenza Vaccines in the United States (2004 – 2019)

9. Rapid Diagnostic Testing for the Management of Influenza

10. Distribution Channel & Technique of Influenza Vaccination in United States

11. United States Influenza Vaccines Reimbursement Policies & Regulatory System
11.1 Reimbursement Policies
11.2 Regulation System

12. Major Deals in the Influenza Vaccines Market
12.1 Merger & Acquisitions
12.2 Collaboration Deal
12.3 Licensing Agreement
12.4 Exclusive Agreement
12.5 Distribution Agreement

13. Promising Influenza Vaccines in the Clinical Development

14. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
14.1 Year 2018
14.2 Year 2017

15. Key Companies Analysis

The report is readily available and can be dispatched immediately after payment confirmation.

More Information @
https://dpiresearch.com/reports/influenza-vaccines-in-the-united-states/

Would like to place an order or any question, please feel free to contact at [email protected]

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

Contact Us:
Maria Rai
Head of Business Development
DPI Research | Web: https://dpiresearch.com
Direct Line: +91-766-764-8693
E-mail: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By DPI Research
Phone 07667648693
Business Address Delhi
New Delhi
Country India
Categories Business , Health , Medical
Tags fluvaccines , vaccine , vaccinemarket
Last Updated November 28, 2019